1, the difference of targeted diseases: reboxetil is mainly used to treat advanced breast cancer with hormone receptor positive and HER2 negative. Besides breast cancer, abexil can also be used to treat other HER2-positive solid tumors, such as gastric cancer and esophageal cancer.
2. Difference of adverse reactions: The adverse reactions of Rebosi are relatively mild, and the common discomfort symptoms are fatigue, nausea, vomiting, diarrhea and headache. The adverse reactions of Abeixi are more obvious, and the common discomfort symptoms are nausea, diarrhea, fatigue, hair loss, loss of appetite and so on.